Taurine adds mitochondrial protection and antioxidant support the classic formula does not address
doi: 10.1007/s00726-010-0749-2
GLP-1 Agonists: Treatment Failure Does Not Preclude Prevention The November 2025 announcement from Novo Nordisk that oral semaglutide failed to slow Alzheimers progression in the EVOKE and EVOKE+ trials was widely reported as a setback
"It's put a lot of resources into marketing the drug, hundreds of millions of dollars to expand the market get new patients for the drug, but it hasn't spent that money on warning patients of the risk of gastroparesis, ileus, small bowel obstruction, and the fact that these injuries can be severe, even if it's in a rare case," said Gantt's attorney, Parvin Aminolroaya
People with conditions like pernicious anemia or Crohns disease, which make it hard to absorb B12 from food or supplements, may also benefit from B12 injections
However, triple receptor agonism, or agonism/antagonism combinations, can be achieved not only though unimolecular triple agonists, but also by combining mono- and dual-agonists